Cargando…
Therapeutic Targeting of Cancer Stem Cells
Recent breakthroughs in translational oncology are opening new perspectives for the treatment of cancer. The advent of targeted therapies has provided the proof-of-concept to selectively turn-off deregulated oncogenic proteins, while the identification and validation of predictive biomarkers of resp...
Autores principales: | Maugeri-Saccà, Marcello, Zeuner, Ann, De Maria, Ruggero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356019/ https://www.ncbi.nlm.nih.gov/pubmed/22655230 http://dx.doi.org/10.3389/fonc.2011.00010 |
Ejemplares similares
-
Biological and clinical implications of cancer stem cells in primary brain tumors
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2013) -
Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue
por: Loria, Rossella, et al.
Publicado: (2022) -
Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue
por: Loria, Rossella, et al.
Publicado: (2022) -
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
por: Bartucci, M, et al.
Publicado: (2012) -
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
por: De Angelis, Maria Laura, et al.
Publicado: (2019)